GSK icon

GSK
GSK

Overview Fund Activity

785 hedge funds and large institutions have $9.34B invested in GSK in 2017 Q1 according to their latest regulatory filings, with 84 funds opening new positions, 303 increasing their positions, 266 reducing their positions, and 52 closing their positions.

Holders
785
Holders Change
+24
Holders Change %
+3.15%
% of All Funds
19.57%
Holding in Top 10
11
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+57.14%
% of All Funds
0.27%
New
84
Increased
303
Reduced
266
Closed
52
Calls
$137M
Puts
$84.4M
Net Calls
+$52.5M
Net Calls Change
+$36.1M

Top Buyers

1
Arrowstreet Capital
1
Arrowstreet Capital
Massachusetts
$257M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$996M
3
Wells Fargo
3
Wells Fargo
California
$491M
4
Thrivent Financial for Lutherans
4
Thrivent Financial for Lutherans
Minnesota
$57.9M
5
Renaissance Technologies
5
Renaissance Technologies
New York
$186M

Top Sellers

1
D.E. Shaw & Co
1
D.E. Shaw & Co
New York
$4.96M
2
Millennium Management
2
Millennium Management
New York
$22.1M
3
Grantham, Mayo, Van Otterloo & Co (GMO)
3
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
$25.7M
4
Marshall Wace
4
Marshall Wace
United Kingdom
$0
5
Two Sigma Investments
5
Two Sigma Investments
New York
$86.9M
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$996M 23,635,038 +2,482,009 +12%
Fisher Asset Management
2
Fisher Asset Management
Washington
$505M 11,969,866 +160,366 +1%
Wells Fargo
3
Wells Fargo
California
$491M 11,654,851 +1,604,849 +16%
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$450M 10,678,557 +285,713 +3%
State Street
5
State Street
Massachusetts
$442M 10,491,299 -109,530 -1%
Royal Bank of Canada
6
Royal Bank of Canada
Ontario, Canada
$367M 8,708,084 +293,195 +3%
Hotchkis & Wiley Capital Management
7
Hotchkis & Wiley Capital Management
California
$317M 7,524,627 -282,573 -4%
Bank of America
8
Bank of America
North Carolina
$289M 6,849,632 +934,928 +16%
Arrowstreet Capital
9
Arrowstreet Capital
Massachusetts
$257M 6,106,306 +6,106,306 New
Bank of New York Mellon
10
Bank of New York Mellon
New York
$249M 5,914,985 -92,278 -2%
Renaissance Technologies
11
Renaissance Technologies
New York
$186M 4,402,100 +1,316,600 +43%
Morgan Stanley
12
Morgan Stanley
New York
$172M 4,078,260 -536,033 -12%
Ameriprise
13
Ameriprise
Minnesota
$158M 3,713,030 -208,467 -5%
Federated Hermes
14
Federated Hermes
Pennsylvania
$155M 3,677,654 -64,266 -2%
BIP
15
Brandes Investment Partners
California
$142M 3,363,788 +214,167 +7%
Goldman Sachs
16
Goldman Sachs
New York
$137M 3,256,289 -60,698 -2%
RJA
17
Raymond James & Associates
Florida
$136M 3,221,035 +288,405 +10%
Northern Trust
18
Northern Trust
Illinois
$126M 2,992,648 +32,226 +1%
EIC
19
Equity Investment Corp
Georgia
$118M 2,792,497 +463,028 +20%
NIMC
20
NWQ Investment Management Company
California
$111M 2,568,415 +402 +0%
Macquarie Group
21
Macquarie Group
Australia
$107M 2,539,877 +119,899 +5%
Two Sigma Advisers
22
Two Sigma Advisers
New York
$100M 2,373,742 -70,000 -3%
SCCM
23
Schafer Cullen Capital Management
New York
$97.2M 2,305,384 +156,228 +7%
UBS Group
24
UBS Group
Switzerland
$90.8M 2,153,951 +81,816 +4%
MHI
25
Miller Howard Investments
New York
$90.5M 2,147,415 +99,035 +5%
1
2 3 4 5